GHRH Analog

Tesamorelin

Also known as: TH9507, GHRH(1-44) analog

Research summary

Tesamorelin is a synthetic 44-amino-acid analog of growth-hormone-releasing hormone (GHRH) with a trans-3-hexenoyl modification on the N-terminus that increases stability in plasma. In research settings it is studied as a tool compound for probing the GHRH receptor and downstream growth-hormone / IGF-1 signaling. All laboratory work with tesamorelin in this catalog is for in-vitro research use only.

Research areas studied

  • GHRH-receptor binding and activation studies
  • Pulsatile growth-hormone secretion research in cell and tissue models
  • IGF-1 axis signaling research
  • Receptor-mediated cAMP signaling studies in pituitary cell models
  • Peptide stability and analytical characterization (HPLC, LC-MS, FTIR)

Specifications

Molecular weight
~5135.8 g/mol
CAS number
218949-48-5
Category
GHRH Analog
Use restriction
For in-vitro research use only

Frequently asked questions

What is tesamorelin?

Tesamorelin is a stabilized synthetic analog of growth-hormone-releasing hormone (GHRH) used in laboratory research as a tool compound for studying the GHRH receptor and growth-hormone secretion pathways.

How is tesamorelin different from sermorelin?

Both are GHRH analogs. Sermorelin corresponds to the first 29 amino acids of GHRH, while tesamorelin is a full-length GHRH(1-44) analog with an N-terminal trans-3-hexenoyl modification that improves plasma stability in research models.

What is the molecular weight of tesamorelin?

Tesamorelin has an approximate molecular weight of 5135.8 g/mol, consistent with a 44-residue GHRH analog carrying a trans-3-hexenoyl N-terminal modification.

Is tesamorelin available for human use through this catalog?

No. Every compound in this catalog, including tesamorelin, is supplied strictly for in-vitro laboratory research use only. It is not for human consumption or any form of human use.

Available in our research catalog

Tesamorelin

10mg · lyophilized

View product

Continue reading